Medline ® Abstract for Reference 65
of 'Pulmonary toxicity associated with antineoplastic therapy: Molecularly targeted agents'
Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia.
Orlandi EM, Rocca B, Pazzano AS, Ghio S
Leuk Res. 2012;36(1):e4. Epub 2011 Sep 3.